Fullcircle Wealth LLC Summit Therapeutics Inc. Transaction History
Fullcircle Wealth LLC
- $244 Billion
- Q4 2024
A detailed history of Fullcircle Wealth LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Fullcircle Wealth LLC holds 16,365 shares of SMMT stock, worth $332,536. This represents 0.15% of its overall portfolio holdings.
Number of Shares
16,365
Previous 11,250
45.47%
Holding current value
$332,536
Previous $250 Million
42.72%
% of portfolio
0.15%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
232Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$496 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$237 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$160 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$133 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$114 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.09B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...